A 26-year-ald, 5-month pregnant consulted her OB Gyne for fear that something is wrong with her baby. In previous routine visit she noted that her baby was moving frequently but in the past 2 days she has notfelt any movements. The OB GYNE noted fetal heart rate is tachycardic, then ordered an ultrasound wheffe significant pleural and pericardial effusion were found. A diagnosis of potential hydrops fetalis is made with additional diagnostic tests ordered. Which of the following is MOST closely associated with non-immune (Rh)-mediated hydroge fetalis? A. Thalassemia minor B. Hemoglobin baris C . Thalassemia major D. Hemoglobin h disease
non-immune hydrops fetalis thalassemia hemoglobin Bart's causes
| Condition | Alpha-gene deletions | Clinical Effect |
|---|---|---|
| Thalassemia minor (alpha trait) | 1–2 gene deletions | Mild microcytosis, clinically silent/minor anemia |
| Hemoglobin H disease | 3 gene deletions | Moderate hemolytic anemia, splenomegaly |
| Hb Bart's (hydrops fetalis) | 4 gene deletions | Fatal in utero — causes hydrops fetalis |
| Thalassemia major (beta) | Beta-gene mutations | Severe post-natal anemia (not hydrops) |
You were listening to product presenta@on by a pharmaceu@cal company of their new an@pyre@c medica@on. They explained that the drug causes lysis of fever aKer 8 hours. Using your knowledge of pharmacology, you deduced that the drug’s half-life is A. 8 hours B. 6 hours C. 4 hours D. 2 hours
drug half-life steady state pharmacokinetics time to effect clinical response
It takes ~4 half-lives for a drug to reach ~94% of its steady-state concentration (or conversely, to fall to ~6% of its original level after discontinuation).
| Number of Half-Lives | % Steady State Reached |
|---|---|
| 1 | 50% |
| 2 | 75% |
| 3 | 87.5% |
| 4 | ~94% (clinically effective) |
| 5 | ~97% |